Research / ECVT / Fundamental state Inspectable configuration
State dimensions Filing 0001708035-23-000007 General Corporate
Debt relative to revenue 0th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.debt_to_revenue
106.67% · OPTIONAL · VALID
Capex intensity 37th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.18% · OPTIONAL · VALID
Operating cash generation 79th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
22.75% · OPTIONAL · VALID
Revenue growth 80th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
34.19% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
5.41% · OPTIONAL · VALID
Gross margin 84th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
27.39% · CORE · VALID
Operating margin 79th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
12.73% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.88% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 74th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.52% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 376.98%
Current 106.67%
Delta -270.31% Capex Intensity Increased
Previous 5.87%
Current 7.18%
Delta 1.31% Cash Generation Decreased
Previous 24.28%
Current 22.75%
Delta -1.53% Growth Decreased
Previous 38.89%
Current 34.19%
Delta -4.70% Inventory Pressure Decreased
Previous 21.39%
Current 5.41%
Delta -15.98% Margin Decreased
Previous 29.10%
Current 27.39%
Delta -1.71% Profitability Decreased
Previous 16.57%
Current 12.73%
Delta -3.84% Sbc Intensity Increased
Previous 2.04%
Current 2.52%
Delta 0.48% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.